Open AccessPhase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Author(s) -
Siqing Fu,
Bradley R. Corr,
Kerry Culm-Merdek,
Colleen Mockbee,
Hagop Youssoufian,
Robert Stagg,
R. Wendel Naumann,
Robert M. Wenham,
Rafael D. Rosengarten,
Laura E. Benjamin,
Erika Hamilton,
Kathleen N. Moore
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.21.01801
Subject(s) - medicine , ovarian cancer , paclitaxel , fallopian tube cancer , neutropenia , gastroenterology , biomarker , cancer , tumor microenvironment , chemotherapy , oncology , biochemistry , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom